Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

This study has been completed.
Sponsor:
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00541476
First received: October 8, 2007
Last updated: November 20, 2008
Last verified: November 2008
  Purpose

The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.


Condition Phase
Neuralgia
Phase 4

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Undergoing Symptomatic Treatment With Lyrica

Further study details as provided by Pfizer:

Enrollment: 746
Study Start Date: June 2007
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of peripheral or central neuropathic pain

Exclusion Criteria:

  • None. Patients recruited by physician decision. Patient's personal data are not collected.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00541476

Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
  More Information

Additional Information:
No publications provided

Responsible Party: Director, Clinical Trials Disclosure Group, Pfizer, Inc
ClinicalTrials.gov Identifier: NCT00541476     History of Changes
Other Study ID Numbers: A0081178
Study First Received: October 8, 2007
Last Updated: November 20, 2008
Health Authority: Czech Republic: Ethics Committee

Additional relevant MeSH terms:
Neuralgia
Pain
Neurologic Manifestations
Nervous System Diseases
Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on September 30, 2014